Open Access<p>A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]</p>
Author(s) -
Joseph Tauber,
Barry A. Schechter,
Jason Bacharach,
Melissa Toyos,
Robert Smyth-Medina,
Sidney L Weiss,
Jodi Luchs
Publication year - 2019
Publication title -
clinical ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.025
H-Index - 56
eISSN - 1177-5483
pISSN - 1177-5467
DOI - 10.2147/opth.s201658
Subject(s) - medicine , dose ranging study , ophthalmology , double blind , alternative medicine , pathology , placebo
[This corrects the article on p. 1921 in vol. 12, PMID: 30323548.].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom